Assured Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Assured Investment Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-31,684	Closed	-$619K	–	1456
2018 Q4	$619K	Buy	31,684 +8,480	+37%	+$166K	0.02%	587
2018 Q3	$454K	Sell	23,204 -19,474	-46%	-$370K	0.01%	796
2018 Q2	$707K	Sell	42,678 -26,201	-38%	-$400K	0.01%	697
2018 Q1	$978K	Buy	+68,879	New	+$1.02M	0.02%	555
2017 Q4	–	Sell	-28,079	Closed	-$356K	–	702
2017 Q3	$356K	Sell	28,079 -82,414	-75%	-$1.05M	0.01%	521
2017 Q2	$1.31M	Buy	+110,493	New	+$1.37M	0.03%	344
2017 Q1	–	Sell	-50,299	Closed	-$814K	–	772
2016 Q4	$814K	Buy	50,299 +14,785	+42%	+$268K	0.02%	364
2016 Q3	$644K	Buy	+35,514	New	+$694K	0.01%	392

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Assured Investment Management's HZNP Position: Q1 2019 in Review

Assured Investment Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2019, closing a stake of 31,684 shares — an estimated $619K sold.

Assured Investment Management first reported a position in HZNP in Q3 2016 and held it in 8 quarters. The position peaked at $1.31M in Q2 2017. 297 funds tracked by Wall St. Rank hold HZNP as of Q1 2019.

Assured Investment Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2019 after selling out during the quarter.
Assured Investment Management sold 31,684 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2019, an estimated $619K.
Assured Investment Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2016 and held it in 8 quarters.
Assured Investment Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.31M in Q2 2017.
297 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2019.

Based on Assured Investment Management's 13F filing for Q1 2019, filed 16 May 2019.